(Total Views: 323)
Posted On: 05/08/2024 11:05:48 AM
Post# of 107064
$TEVA News Article - Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia https://marketwirenews.com/news-releases/teva...69061.html
(0)
(0)
My Twitter: WhyteStocks
